Fibromodulin Ablation Exacerbates the Severity of Acute Colitis

References

• Zhou J, Lai W, Yang W, et al. BLT1 in dendritic cells promotes Th1/Th17 differentiation and its deficiency ameliorates TNBS-induced colitis. Cell Mol Immunol. 2018;15:1047–1056. doi:10.1038/s41423-018-0030-2
   PubMed Web of Science ®Google Scholar
• Ordas I, Eckmann L, Talamini M, Baumgart DC, Sandborn WJ. Ulcerative colitis. Lancet. 2012;380:1606–1619. doi:10.1016/S0140-6736(12)60150-0
   PubMed Web of Science ®Google Scholar
• Zou J, Liu C, Jiang S, Qian D, Duan J. Cross talk between gut microbiota and intestinal mucosal immunity in the development of ulcerative colitis. Infect Immun. 2021;89:e0001421. doi:10.1128/IAI.00014-21
   PubMed Web of Science ®Google Scholar
• Torres J, Mehandru S, Colombel JF, Peyrin-Biroulet L. Crohn’s disease. Lancet. 2017;389:1741–1755. doi:10.1016/S0140-6736(16)31711-1
   PubMed Web of Science ®Google Scholar
• Bischoff SC, Barbara G, Buurman W, et al. Intestinal permeability–a new target for disease prevention and therapy. BMC Gastroenterol. 2014;14:189. doi:10.1186/s12876-014-0189-7
   PubMed Web of Science ®Google Scholar
• Paris L, Tonutti L, Vannini C, Bazzoni G. Structural organization of the tight junctions. Biochim Biophys Acta. 2008;1778:646–659. doi:10.1016/j.bbamem.2007.08.004
   PubMed Web of Science ®Google Scholar
• Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature. 1998;392:245–252. doi:10.1038/32588
   PubMed Web of Science ®Google Scholar
• Rescigno M, Granucci F, Citterio S, Foti M, Ricciardi-Castagnoli P. Coordinated events during bacteria-induced DC maturation. Immunol Today. 1999;20:200–203. doi:10.1016/S0167-5699(98)01427-3
   PubMedGoogle Scholar
• Huang FP, Platt N, Wykes M, et al. A discrete subpopulation of dendritic cells transports apoptotic intestinal epithelial cells to T cell areas of mesenteric lymph nodes. J Exp Med. 2000;191:435–444. doi:10.1084/jem.191.3.435
   PubMed Web of Science ®Google Scholar
• Sjoberg A, Onnerfjord P, Morgelin M, Heinegard D, Blom AM. The extracellular matrix and inflammation: fibromodulin activates the classical pathway of complement by directly binding C1q. J Biol Chem. 2005;280:32301–32308. doi:10.1074/jbc.M504828200
   PubMed Web of Science ®Google Scholar
• Merle NS, Noe R, Halbwachs-Mecarelli L, Fremeaux-Bacchi V, Roumenina LT. Complement system part II: role in immunity. Front Immunol. 2015;6:257. doi:10.3389/fimmu.2015.00257
   PubMed Web of Science ®Google Scholar
• Adini I, Ghosh K, Adini A, et al. Melanocyte-secreted fibromodulin promotes an angiogenic microenvironment. J Clin Invest. 2014;124:425–436. doi:10.1172/JCI69404
   PubMed Web of Science ®Google Scholar
• Adini I, Adini A, Bazinet L, Watnick RS, Bielenberg DR, D’Amato RJ. Melanocyte pigmentation inversely correlates with MCP-1 production and angiogenesis-inducing potential. FASEB J. 2015;29:662–670. doi:10.1096/fj.14-255398
   PubMed Web of Science ®Google Scholar
• Kontos CD. More than skin deep: connecting melanocyte pigmentation and angiogenic diseases. J Clin Invest. 2014;124:76–79. doi:10.1172/JCI73559
   PubMed Web of Science ®Google Scholar
• Howe KL, Reardon C, Wang A, Nazli A, McKay DM. Transforming growth factor-beta regulation of epithelial tight junction proteins enhances barrier function and blocks enterohemorrhagic Escherichia coli O157: H7-induced increased permeability. Am J Pathol. 2005;167:1587–1597. doi:10.1016/S0002-9440(10)61243-6
   PubMed Web of Science ®Google Scholar
• Kel JM, Girard-Madoux MJ, Reizis B, Clausen BE. TGF-beta is required to maintain the pool of immature Langerhans cells in the epidermis. J Immunol. 2010;185:3248–3255. doi:10.4049/jimmunol.1000981
   PubMed Web of Science ®Google Scholar
• Schultz HS, Nitze LM, Zeuthen LH, et al. Collagen induces maturation of human monocyte-derived dendritic cells by signaling through osteoclast-associated receptor. J Immunol. 2015;194:3169–3179. doi:10.4049/jimmunol.1402800
   PubMed Web of Science ®Google Scholar
• Brand U, Bellinghausen I, Enk AH, et al. Influence of extracellular matrix proteins on the development of cultured human dendritic cells. Eur J Immunol. 1998;28:1673–1680. doi:10.1002/(SICI)1521-4141(199805)28:05<1673::AID-IMMU1673>3.0.CO;2-J
   PubMed Web of Science ®Google Scholar
• Hall LJ, Faivre E, Quinlan A, Shanahan F, Nally K, Melgar S. Induction and activation of adaptive immune populations during acute and chronic phases of a murine model of experimental colitis. Dig Dis Sci. 2011;56:79–89. doi:10.1007/s10620-010-1240-3
   PubMed Web of Science ®Google Scholar
• Arimura K, Takagi H, Uto T, et al. Crucial role of plasmacytoid dendritic cells in the development of acute colitis through the regulation of intestinal inflammation. Mucosal Immunol. 2017;10:957–970. doi:10.1038/mi.2016.96
   PubMed Web of Science ®Google Scholar
• Poritz LS, Garver KI, Green C, Fitzpatrick L, Ruggiero F, Koltun WA. Loss of the tight junction protein ZO-1 in dextran sulfate sodium induced colitis. J Surg Res. 2007;140:12–19. doi:10.1016/j.jss.2006.07.050
   PubMed Web of Science ®Google Scholar
• Noth R, Lange-Grumfeld J, Stüber E, et al. Increased intestinal permeability and tight junction disruption by altered expression and localization of occludin in a murine graft versus host disease model. BMC Gastroenterol. 2011;11(1):109. doi:10.1186/1471-230X-11-109
   PubMed Web of Science ®Google Scholar
• Poritz LS, Harris LR 3rd, Kelly AA, Koltun WA. Increase in the tight junction protein claudin-1 in intestinal inflammation. Dig Dis Sci. 2011;56:2802–2809. doi:10.1007/s10620-011-1688-9
   PubMed Web of Science ®Google Scholar
• te Velde AA, de Kort F, Sterrenburg E, et al. Comparative analysis of colonic gene expression of three experimental colitis models mimicking inflammatory bowel disease. Inflamm Bowel Dis. 2007;13(3):325–330. doi:10.1002/ibd.20079
   PubMed Web of Science ®Google Scholar
• Yan Y, Kolachala V, Dalmasso G, et al. Temporal and spatial analysis of clinical and molecular parameters in dextran sodium sulfate induced colitis. PLoS One. 2009;4:e6073. doi:10.1371/journal.pone.0006073
   PubMed Web of Science ®Google Scholar
• Arseneau KO, Cominelli F. Targeting leukocyte trafficking for the treatment of inflammatory bowel disease. Clin Pharmacol Ther. 2015;97:22–28. doi:10.1002/cpt.6
   PubMed Web of Science ®Google Scholar
• Houston SA, Cerovic V, Thomson C, et al. The lymph nodes draining the small intestine and colon are anatomically separate and immunologically distinct. Mucosal Immunol. 2016;9:468–478. doi:10.1038/mi.2015.77
   PubMed Web of Science ®Google Scholar
• Mikaelsson E, Danesh-Manesh AH, Luppert A, et al. Fibromodulin, an extracellular matrix protein: characterization of its unique gene and protein expression in B-cell chronic lymphocytic leukemia and mantle cell lymphoma. Blood. 2005;105:4828–4835. doi:10.1182/blood-2004-10-3941
   PubMed Web of Science ®Google Scholar
• Iozzo RV, Schaefer L. Proteoglycan form and function: a comprehensive nomenclature of proteoglycans. Matrix Biol. 2015;42:11–55. doi:10.1016/j.matbio.2015.02.003
   PubMed Web of Science ®Google Scholar
• Heinegard D, Larsson T, Sommarin Y, et al. Two novel matrix proteins isolated from articular cartilage show wide distributions among connective tissues. J Biol Chem. 1986;261:13866–13872. doi:10.1016/S0021-9258(18)67101-7
   PubMed Web of Science ®Google Scholar
• Lee YH, Schiemann WP. Fibromodulin suppresses nuclear factor-kappaB activity by inducing the delayed degradation of IKBA via a JNK-dependent pathway coupled to fibroblast apoptosis. J Biol Chem. 2011;286:6414–6422. doi:10.1074/jbc.M110.168682
   PubMed Web of Science ®Google Scholar
• Lee EJ, Jan AT, Baig MH, et al. Fibromodulin: a master regulator of myostatin controlling progression of satellite cells through a myogenic program. FASEB J. 2016;30:2708–2719. doi:10.1096/fj.201500133R
   PubMed Web of Science ®Google Scholar
• Zheng Z, Jian J, Zhang X, et al. Reprogramming of human fibroblasts into multipotent cells with a single ECM proteoglycan, fibromodulin. Biomaterials. 2012;33:5821–5831. doi:10.1016/j.biomaterials.2012.04.049
   PubMed Web of Science ®Google Scholar
• Zheng Z, Jian J, Velasco O, et al. Fibromodulin enhances angiogenesis during cutaneous wound healing. Plast Reconstr Surg Glob Open. 2014;2:e275. doi:10.1097/GOX.0000000000000243
   PubMedGoogle Scholar
• Jan AT, Lee EJ, Choi I. Fibromodulin: a regulatory molecule maintaining cellular architecture for normal cellular function. Int J Biochem Cell Biol. 2016;80:66–70. doi:10.1016/j.biocel.2016.09.023
   PubMed Web of Science ®Google Scholar
• Zeng-Brouwers J, Pandey S, Trebicka J, Wygrecka M, Schaefer L. Communications via the small leucine-rich proteoglycans: molecular specificity in inflammation and autoimmune diseases. J Histochem Cytochem. 2020;68:887–906. doi:10.1369/0022155420930303
   PubMed Web of Science ®Google Scholar
• Schaefer L, Gröne H-J, Raslik I, et al. Small proteoglycans of normal adult human kidney: distinct expression patterns of decorin, biglycan, fibromodulin, and lumican. Kidney Int. 2000;58:1557–1568. doi:10.1046/j.1523-1755.2000.00317.x
   PubMed Web of Science ®Google Scholar
• Mormone E, Lu Y, Ge X, Fiel MI, Nieto N. Fibromodulin, an oxidative stress-sensitive proteoglycan, regulates the fibrogenic response to liver injury in mice. Gastroenterology. 2012;142:612 e615–621 e615. doi:10.1053/j.gastro.2011.11.029
   Web of Science ®Google Scholar
• Perse M, Cerar A. Dextran sodium sulphate colitis mouse model: traps and tricks. J Biomed Biotechnol. 2012;2012:718617. doi:10.1155/2012/718617
   PubMedGoogle Scholar
• Martini E, Krug SM, Siegmund B, Neurath MF, Becker C. Mend your fences: the epithelial barrier and its relationship with mucosal immunity in inflammatory bowel disease. Cell Mol Gastroenterol Hepatol. 2017;4:33–46. doi:10.1016/j.jcmgh.2017.03.007
   PubMed Web of Science ®Google Scholar
• Lee JY, Wasinger V, Yau Y, et al. Molecular pathophysiology of epithelial barrier dysfunction in inflammatory bowel diseases. Proteomes. 2018;6:17. doi:10.3390/proteomes6020017
   PubMed Web of Science ®Google Scholar
• Heeger PS, Kemper C. Novel roles of complement in T effector cell regulation. Immunobiology. 2012;217:216–224. doi:10.1016/j.imbio.2011.06.004
   PubMed Web of Science ®Google Scholar
• Son M, Santiago-Schwarz F, Al-Abed Y, Diamond B. C1q limits dendritic cell differentiation and activation by engaging LAIR-1. Proc Natl Acad Sci USA. 2012;109:E3160–E3167. doi:10.1073/pnas.1212753109
   PubMed Web of Science ®Google Scholar
• Lood C, Gullstrand B, Truedsson L, et al. C1q inhibits immune complex-induced interferon-alpha production in plasmacytoid dendritic cells: a novel link between C1q deficiency and systemic lupus erythematosus pathogenesis. Arthritis Rheum. 2009;60:3081–3090. doi:10.1002/art.24852
   PubMed Web of Science ®Google Scholar
• Bencze D, Fekete T, Pazmandi K. Type I interferon production of plasmacytoid dendritic cells under control. Int J Mol Sci. 2021;22:4190. doi:10.3390/ijms22084190
   PubMed Web of Science ®Google Scholar